Induction of p53 accumulation by Moloney murine leukemia virus-ts1 infection in astrocytes via activation of extracellular signal-regulated kinases 1/2

Laboratory Investigation

Volumn 82, Issue 6, 2002, Pages 693-702

  Kim, Hun Taek ^a   Tasca, Serban ^a   Qiang, Wenan ^b   Wong, Paul K Y ^b   Stoica, George ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN BAX; PROTEIN P21; PROTEIN P53;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN STEM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOLONEY MURINE SARCOMA ONCOVIRUS; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BCL-2-ASSOCIATED X PROTEIN; BRAIN STEM; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENCEPHALITIS, VIRAL; ENZYME INHIBITORS; FLAVONOIDS; LEUKEMIA, EXPERIMENTAL; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MOLONEY MURINE LEUKEMIA VIRUS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036278878     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000017373.82871.45     Document Type: Article

References (61)

1. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: Possible involvement of Tax1 in the altered expression of cyclin D2, p18ink4 and p21waf1/cip1/sdi1
2. PD 098059 is a specific inhibitor of the activation of mitogen activated protein kinase in vitro and in vivo
3. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures
4. P53 functional impairment and high p21 (waf1/cip1) expression in human T-cell lymphotroplc/leukemia virus type I-transformed T cells
5. Neurodegeneration induced by MoMuLV-ts1 and increased expression of Fas and TNF-α in the central nervous system
6. Progressive multifocal leukoencephalopathy and oligodendroglioma in a monkey co-infected by simian immunodeficiency virus and simian virus 40
7. Signaling by dual specificity kinases
8. A synthetic inhibitor of the mitogen-activated protein kinase cascade
9. Accumulation of p53 in infectious mononucleosis tissues
10. MEKK1/JNK signaling stabilizes and activates p53
11. Stress-activated kinases regulate protein stability
12. Type C viruses of wild mice: Characterization and natural history of amphotropic, ecotropic, and xenotropic MuLV
13. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism
14. The complexity of p53 modulation: Emerging patterns from divergent signals
15. Biochemical properties and biological effects of p53
16. Mdm2 promotes the rapid degradation of p53
17. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
18. Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress
19. Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis
20. Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls
21. The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53
22. Enhanced proteolysis of IκBα and IκBβ proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: A potential mechanism of NF-κB activation
23. Regulation of p53 stability by Mdm2
24. P53, the cellular gatekeeper for growth and division
25. Signal transduction through MAP kinase cascades
26. Establishment and characterization of conditionally immortalized astrocytes to study their interaction with ts1, a neuropathogenic mutant of Moloney murine leukemia virus
27. Increase in p53 protein half-life in mouse keratinocytes following UV-B irradiation
28. In vivo ubiquitination and proteasome-mediated degradation of p53
29. Activation of c-Jun N-terminal kinase by herpes simplex virus type I enhances viral replication
30. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
31. Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase
32. Negative feedback regulation of wild-type p53 biosynthesis
33. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures
34. Proteolysis by calpains: A possible contribution to degradation of p53
35. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition
36. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin
37. Murine C-type RNA virus from spontaneous neoplasms: In vitro host range and oncogenic potential
38. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor
39. Mitogen-activated protein kinase pathways
40. Viruses and apoptosis
41. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation
42. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
43. Correlation of specific virus-astrocyte interactions and cytopathic effects induced by ts1, a neurovirulent mutant of Moloney murine leukemia virus
44. DNA damage induces phosphorylation of the amino terminus of p53
45. Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha, 25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: A structure-function study
46. Temporal central and peripheral nervous system changes induced by a paralytogenic mutant of Moloney murine leukemia virus TB
47. Motor neuronal loss and neurofilament-ubiquitin alteration in MoMuLV-ts1 encephalopathy
48. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
49. Identification of a novel p53 promoter element involved in genotoxic stress inducible p53 gene expression
50. A Val-25-to-Ile substitution in the envelope precursor polyprotein, gPr80env, is responsible for the temperature sensitivity, inefficient processing of gPr80env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB
51. Corneal infection of herpes simplex virus type 2-induced neuronal apoptosis in the brain stem of mice with expression of tumor suppressor gene (p53) and transcription factors
52. Signal transduction pathways and modulation of gene activity
53. High susceptibility of FVB/N mice to the paralytic disease induced by ts1, a mutant of Moloney murine leukemia virus TB
54. Ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice
55. Replication of murine leukemia virus in heterologous cells: Interaction between ecotropic and xenotropic viruses
56. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
57. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases
58. Control of protein phosphatase 2A by simian virus 40 small-t antigen
59. Expression of Bax, Bcl-2, and P53 in progressive multifocal leukoencephalopathy
60. The reduced virulence of the thymotrophic Moloney murine leukemia virus derivative MoMuLV-TB is mapped to 11 mutations within the U3 region of the long terminal repeat
61. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1